{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T01:04:58Z","timestamp":1791162298989,"version":"4.1.0"},"reference-count":126,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2000,2,1]],"date-time":"2000-02-01T00:00:00Z","timestamp":949363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2000,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Molecular alterations in proto-oncogenes, tumour suppressor genes, and genes that function in DNA damage recognition and repair are considered to be hallmarks of a carcinogenic process, including breast carcinogenesis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A computer-assisted search of the English literature (Medline database, 1990\u20131999) was performed, followed by a manual search of the reference list of pertinent articles retrieved.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Hereditary breast cancer accounts for 5\u201310 per cent of all breast cancer cases. About 90 per cent of hereditary breast cancers involve mutation of the BRCA1 and\/or BRCA2 genes. Other cancer-related genes (including myc, c-erbB2, Tsg101 and Mdgi) are involved in breast carcinogenesis, but they do not give rise to familial breast cancer syndromes. Risk estimation is the most important clinical implication. Management options for the high-risk mutation carriers include cancer surveillance and preventive strategies (prophylactic surgery or chemoprevention).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Despite inadequate knowledge about the genetic predisposition to breast cancer and its clinical implications, the demand for genetic testing is likely to expand rapidly. In addition to risk estimation, cancer surveillance and preventive strategies, gene therapy offers a new and theoretically attractive approach to breast cancer management.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1046\/j.1365-2168.2000.01347.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T07:13:28Z","timestamp":1047366808000},"page":"149-162","source":"Crossref","is-referenced-by-count":24,"title":["Genetic predisposition to breast cancer: a surgical perspective"],"prefix":"10.1093","volume":"87","author":[{"given":"G H","family":"Sakorafas","sequence":"first","affiliation":[{"name":"Department of Surgery, 251 Hellenic Air Force Hospital, Messogion and Katehaki , Athens 115 25,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A G","family":"Tsiotou","sequence":"additional","affiliation":[{"name":"Department of Surgery, 251 Hellenic Air Force Hospital, Messogion and Katehaki , Athens 115 25,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2000,2,1]]},"reference":[{"key":"2024093005204318900_bib1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/canjclin.47.1.5","article-title":"Cancer statistics 1997","volume":"47","author":"Parker","year":"1997","journal-title":"CA Cancer J Clin"},{"key":"2024093005204318900_bib2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/canjclin.46.1.5","article-title":"Cancer statistics 1996","volume":"46","author":"Parker","year":"1996","journal-title":"CA Cancer J Clin"},{"key":"2024093005204318900_bib3","volume-title":"Breast Cancer, Monograph","author":"Sakorafas","year":"1999"},{"key":"2024093005204318900_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1524-4741.1997.tb00200.x","article-title":"Breast cancer genes","volume":"3","author":"Bowcock","year":"1997","journal-title":"Breast J"},{"key":"2024093005204318900_bib5","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1615\/CritRevOncog.v6.i3-6.40","article-title":"Genetic, epigenetic, dysgenetic, and non-genetic mechanisms in tumorigenesis","volume":"6","author":"Simons","year":"1995","journal-title":"Crit Rev Oncog"},{"key":"2024093005204318900_bib6","volume-title":"Oncogenes: Their Clinical Significance","author":"Sakorafas","year":"1993"},{"key":"2024093005204318900_bib7","first-page":"17","article-title":"The molecular basis of cancer","volume":"31","author":"Sakorafas","year":"1995","journal-title":"Hellenic Oncology"},{"key":"2024093005204318900_bib8","first-page":"36","article-title":"Oncogenes and cancer. The genetic basis of cancer","volume":"65","author":"Sakorafas","year":"1994","journal-title":"Latriki"},{"key":"2024093005204318900_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.1993.tb17187.x","article-title":"Critical steps in breast carcinogenesis","volume":"698","author":"Russo","year":"1993","journal-title":"Ann N Y Acad Sci"},{"key":"2024093005204318900_bib10","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1006\/scbi.1995.0015","article-title":"Preneoplastic transformation of human mammary epithelial cells","volume":"6","author":"Band","year":"1995","journal-title":"Semin Cancer Biol"},{"key":"2024093005204318900_bib11","first-page":"2901","article-title":"Molecular links between cellular mortality and immortality","volume":"16","author":"Derventzi","year":"1996","journal-title":"Anticancer Res"},{"key":"2024093005204318900_bib12","first-page":"403","article-title":"A critical approach to the malignant transformation of human breast epithelial cells with chemical carcinogens","volume":"44","author":"Russo","year":"1993","journal-title":"Crit Rev Oncog"},{"key":"2024093005204318900_bib13","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1053\/ejso.1999.0706","article-title":"Multistep pancreatic carcinogenesis and its clinical implications","volume":"25","author":"Sakorafas","year":"1999","journal-title":"Eur J Surg Oncol"},{"key":"2024093005204318900_bib14","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0748-7983(05)80081-2","article-title":"The genetic basis of colorectal cancer\u2014clinical implications","volume":"21","author":"Tsiotou","year":"1995","journal-title":"Eur J Surg Oncol"},{"key":"2024093005204318900_bib15","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/315190a0","article-title":"Evolution of tumours and the impact of molecular oncology","volume":"315","author":"Klein","year":"1985","journal-title":"Nature"},{"key":"2024093005204318900_bib16","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1002\/1097-0142(19900915)66:14+<1326::AID-CNCR2820661405>3.0.CO;2-P","article-title":"Anatomic markers of human premalignancy and risk of breast cancer. Cancer","volume":"66","author":"Page","year":"1990","journal-title":"Cancer"},{"key":"2024093005204318900_bib17","first-page":"43","article-title":"Molecular epidemiology of breast cancer","volume":"12","author":"Goldman","year":"1998","journal-title":"In Vivo"},{"key":"2024093005204318900_bib18","first-page":"678","article-title":"Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium","volume":"52","author":"Easton","year":"1993","journal-title":"Am J Hum Genet"},{"key":"2024093005204318900_bib19","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1001\/jama.1995.03520310033026","article-title":"A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. Implications for presymptomatic testing and screening","volume":"273","author":"Shattuck-Eidens","year":"1995","journal-title":"JAMA"},{"key":"2024093005204318900_bib20","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/clinchem\/43.1.6","article-title":"BRCA1 mutation testing: controversies and challenges","volume":"43","author":"Petty","year":"1997","journal-title":"Clin Chem"},{"key":"2024093005204318900_bib21","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1056\/NEJM199601183340301","article-title":"BRCA1 mutations in a population-based sample of young women with breast cancer","volume":"334","author":"Langston","year":"1996","journal-title":"N Engl J Med"},{"key":"2024093005204318900_bib22","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1056\/NEJM199601183340302","article-title":"Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer","volume":"334","author":"FitzGerald","year":"1996","journal-title":"N Engl J Med"},{"key":"2024093005204318900_bib23","first-page":"265","article-title":"Breast and ovarian cancer incidence in BRCA1 mutation carriers. Breast Cancer Linkage Consortium","volume":"56","author":"Easton","year":"1995","journal-title":"Am J Hum Genet"},{"key":"2024093005204318900_bib24","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0140-6736(94)91578-4","article-title":"Risk of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium","volume":"343","author":"Ford","year":"1994","journal-title":"Lancet"},{"key":"2024093005204318900_bib25","first-page":"254","article-title":"An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Breast Cancer Linkage Consortium","volume":"56","author":"Narod","year":"1995","journal-title":"Am J Hum Genet"},{"key":"2024093005204318900_bib26","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0165-4608(98)00165-4","article-title":"An update on DNA-based BRCA1\/BRCA2 genetic counseling in hereditary breast cancer","volume":"109","author":"Lynch","year":"1999","journal-title":"Cancer Genet Cytogenet"},{"key":"2024093005204318900_bib27","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/hmg\/4.10.1953","article-title":"Mutation analysis of the BRCA1 gene in 76 Japanese ovarian cancer patients: four germline mutations, but no evidence of somatic mutation","volume":"4","author":"Matsushima","year":"1995","journal-title":"Hum Mol Genet"},{"key":"2024093005204318900_bib28","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/ng0495-439","article-title":"Somatic mutations in the BRCA1 gene in sporadic ovarian tumours","volume":"9","author":"Merajver","year":"1995","journal-title":"Nat Genet"},{"key":"2024093005204318900_bib29","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/ng0495-343","article-title":"A somatic BRCA1 mutation in an ovarian tumour","volume":"9","author":"Hosking","year":"1995","journal-title":"Nat Genet"},{"key":"2024093005204318900_bib30","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1056\/NEJM199601183340311","article-title":"BRCA1\u2014lots of mutations, lots of dilemmas","volume":"334","author":"Collins","year":"1996","journal-title":"N Engl J Med"},{"key":"2024093005204318900_bib31","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1056\/NEJM199705153362001","article-title":"The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews","volume":"336","author":"Struewing","year":"1997","journal-title":"N Engl J Med"},{"key":"2024093005204318900_bib32","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/ng1095-198","article-title":"The carrier frequency of the BRCA1 185delAG mutation is approximately 1% in Ashkenazi Jewish individuals","volume":"11","author":"Struewing","year":"1995","journal-title":"Nat Genet"},{"key":"2024093005204318900_bib33","first-page":"1457","article-title":"Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence","volume":"57","author":"Ford","year":"1995","journal-title":"Am J Hum Genet"},{"key":"2024093005204318900_bib34","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0959-437X(98)80056-7","article-title":"Functions of the BRCA1 and BRCA2 genes","volume":"8","author":"Bertwistle","year":"1998","journal-title":"Curr Opin Genet Devel"},{"key":"2024093005204318900_bib35","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1200\/JCO.1998.16.5.1969","article-title":"BRCA1 and BRCA2: from molecular genetics to clinical medicine","volume":"16","author":"Blackwood","year":"1998","journal-title":"J Clin Oncol"},{"key":"2024093005204318900_bib36","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/humu.1380080102","article-title":"Mutations and polymorphisms in the familial early-onset breast cancer (BRCA1) gene. Breast Cancer Information Core","volume":"8","author":"Couch","year":"1996","journal-title":"Hum Mut"},{"key":"2024093005204318900_bib37","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1126\/science.8091231","article-title":"Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13","volume":"265","author":"Wooster","year":"1994","journal-title":"Science"},{"key":"2024093005204318900_bib38","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/378789a0","article-title":"Identification of the breast cancer susceptibility gene","volume":"378","author":"Wooster","year":"1995","journal-title":"Brca2. Nature"},{"key":"2024093005204318900_bib39","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/0959-8049(94)90190-2","article-title":"The genetics of familial breast cancer and their practical implications","volume":"30A","author":"Eeles","year":"1994","journal-title":"Eur J Cancer"},{"key":"2024093005204318900_bib40","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1093\/hmg\/5.Supplement_1.1515","article-title":"Recent advances in understanding of genetic susceptibility to breast cancer","volume":"5","author":"Stratton","year":"1996","journal-title":"Hum Mol Genet"},{"key":"2024093005204318900_bib41","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/bjc.1995.417","article-title":"The genetics of breast and ovarian cancer","volume":"72","author":"Ford","year":"1995","journal-title":"Br J Cancer"},{"key":"2024093005204318900_bib42","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1001\/jama.1997.03540360065034","article-title":"Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium","volume":"277","author":"Burke","year":"1997","journal-title":"JAMA"},{"key":"2024093005204318900_bib43","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/00001622-199811000-00002","article-title":"Recent advances in breast cancer biology","volume":"10","author":"Eisen","year":"1998","journal-title":"Curr Opin Oncol"},{"key":"2024093005204318900_bib44","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/386761a0","article-title":"Cancer-susceptibility genes. Gatekeepers and caretakers","volume":"386","author":"Kinzler","year":"1997","journal-title":"Nature"},{"key":"2024093005204318900_bib45","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/ng0596-123","article-title":"BRCA2 germline mutations in male breast cancer families","volume":"13","author":"Cough","year":"1996","journal-title":"Nat Genet"},{"key":"2024093005204318900_bib46","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/ng0596-120","article-title":"Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families","volume":"13","author":"Phelan","year":"1996","journal-title":"Nat Genet"},{"key":"2024093005204318900_bib47","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/ng0696-238","article-title":"BRCA2 mutations in primary breast and ovarian cancers","volume":"13","author":"Lancaster","year":"1996","journal-title":"Nat Genet"},{"key":"2024093005204318900_bib48","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/ng0696-245","article-title":"Mutation analysis on the BRCA2 gene in primary breast cancers","volume":"13","author":"Miki","year":"1996","journal-title":"Nat Genet"},{"key":"2024093005204318900_bib49","first-page":"486","article-title":"Mutations in BRCA1 and BRCA2 in breast cancer families: are there more breast cancer susceptibility genes?","volume":"60","author":"Serova","year":"1997","journal-title":"Am J Hum Genet"},{"key":"2024093005204318900_bib50","first-page":"962","article-title":"A somatic truncating mutation in BRCA2 in a sporadic breast tumor","volume":"59","author":"Weber","year":"1996","journal-title":"Am J Hum Genet"},{"key":"2024093005204318900_bib51","first-page":"4356","article-title":"Loss of heterozygosity in familial breast carcinomas","volume":"53","author":"Lindblom","year":"1993","journal-title":"Cancer Res"},{"key":"2024093005204318900_bib52","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/ng0495-444","article-title":"Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression","volume":"9","author":"Thompson","year":"1995","journal-title":"Nat Genet"},{"key":"2024093005204318900_bib53","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/ng0396-298","article-title":"Growth retardation and tumour inhibition by","volume":"12","author":"Holt","year":"1996","journal-title":"Brca1. Nat Genet"},{"key":"2024093005204318900_bib54","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/S0140-6736(96)10109-4","article-title":"Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases","volume":"349","author":"Breast Cancer Linkage Consortium","year":"1997","journal-title":"Lancet"},{"key":"2024093005204318900_bib55","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/(SICI)1097-0142(19970801)80:3<435::AID-CNCR11>3.0.CO;2-Y","article-title":"Influence of BRCA1 mutations on nuclear grade and estrogen receptor status of breast carcinoma in Ashkenazi Jewish women","volume":"80","author":"Karp","year":"1997","journal-title":"Cancer"},{"key":"2024093005204318900_bib56","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0959-8049(97)89007-7","article-title":"Tumour biological features of BRCA1-induced breast and ovarian cancer","volume":"33","author":"Johannsson","year":"1997","journal-title":"Eur J Cancer"},{"key":"2024093005204318900_bib57","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/(SICI)1097-0142(19960215)77:4<697::AID-CNCR16>3.0.CO;2-W","article-title":"Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage","volume":"77","author":"Marcus","year":"1996","journal-title":"Cancer"},{"key":"2024093005204318900_bib58","first-page":"471","article-title":"Germline mutation at BRCA1 affects the histo-prognostic grade in hereditary breast cancer","volume":"56","author":"Eisinger","year":"1996","journal-title":"Cancer Res"},{"key":"2024093005204318900_bib59","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/jnci\/91.3.259","article-title":"Survival after breast cancer in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers","volume":"91","author":"Lee","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"2024093005204318900_bib60","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/jnci\/91.3.201","article-title":"Genetic risk and breast cancer survival: another link in the chain of evidence","volume":"91","author":"Burke","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"2024093005204318900_bib61","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1126\/science.1905840","article-title":"p53 mutations in human cancers","volume":"253","author":"Hollstein","year":"1991","journal-title":"Science"},{"key":"2024093005204318900_bib62","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1126\/science.8023157","article-title":"Crystal structure of a p53 tumor suppressor\u2013DNA complex: understanding tumorigenic mutations","volume":"265","author":"Cho","year":"1994","journal-title":"Science"},{"key":"2024093005204318900_bib63","first-page":"3551","article-title":"Database of p53 gene somatic mutations in human tumors and cell lines","volume":"22","author":"Hollstein","year":"1994","journal-title":"Nucl Acids Res"},{"key":"2024093005204318900_bib64","first-page":"907","article-title":"DNA adducts as exposure biomarkers and indicators of cancer risk","volume":"105","author":"Poirier","year":"1997","journal-title":"Environ Health Perspect"},{"key":"2024093005204318900_bib65","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1126\/science.1978757","article-title":"Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms","volume":"250","author":"Malkin","year":"1990","journal-title":"Science"},{"key":"2024093005204318900_bib66","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/0959-8049(93)90001-V","article-title":"Predictive testing for germline mutations in the p53 gene: are all the questions answered?","volume":"29A","author":"Eeles","year":"1993","journal-title":"Eur J Cancer"},{"key":"2024093005204318900_bib67","first-page":"5358","article-title":"A cancer family syndrome in twenty-four kindreds","volume":"48","author":"Li","year":"1988","journal-title":"Cancer Res"},{"key":"2024093005204318900_bib68","doi-asserted-by":"crossref","first-page":"54","DOI":"10.4065\/72.1.54","article-title":"Genetics of breast cancer","volume":"72","author":"Greene","year":"1997","journal-title":"Mayo Clin Proc"},{"key":"2024093005204318900_bib69","first-page":"3234","article-title":"Screening for germ line TP53 mutations in breast cancer patients","volume":"52","author":"Borressen","year":"1992","journal-title":"Cancer Res"},{"key":"2024093005204318900_bib70","first-page":"2984","article-title":"Inherited p53 gene mutations in breast cancer","volume":"52","author":"Sidransky","year":"1992","journal-title":"Cancer Res"},{"key":"2024093005204318900_bib71","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/ijc.2910460515","article-title":"Patterns of expressions of the p53 tumour suppressor in human breast tissues and tumors in situ and in vitro","volume":"46","author":"Bartek","year":"1990","journal-title":"Int J Cancer"},{"key":"2024093005204318900_bib72","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1136\/jmg.32.2.117","article-title":"Cowden syndrome","volume":"32","author":"Hanssen","year":"1995","journal-title":"J Med Genet"},{"key":"2024093005204318900_bib73","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1093\/hmg\/6.8.1383","article-title":"Germline mutations in the PTEN\/MMAC1 gene in patients with Cowden disease","volume":"6","author":"Nelen","year":"1997","journal-title":"Hum Mol Genet"},{"key":"2024093005204318900_bib74","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/ng0497-356","article-title":"Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers","volume":"15","author":"Steck","year":"1997","journal-title":"Nat Genet"},{"key":"2024093005204318900_bib75","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1126\/science.275.5308.1943","article-title":"PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer","volume":"13","author":"Li","year":"1997","journal-title":"Science"},{"key":"2024093005204318900_bib76","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1086\/301639","article-title":"Inherited mutations in PTEN that are associated with breast cancer, Cowden disease, and juvenile polyposis","volume":"61","author":"Lynch","year":"1997","journal-title":"Am J Hum Genet"},{"key":"2024093005204318900_bib77","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0039-6109(05)70434-5","article-title":"Inherited breast cancer","volume":"76","author":"Radford","year":"1996","journal-title":"Surg Clin North Am"},{"key":"2024093005204318900_bib78","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1046\/j.1440-1622.1999.01515.x","article-title":"The genetic basis of breast cancer and its clinical implications","volume":"69","author":"Bennett","year":"1999","journal-title":"Aust N Z J Surg"},{"key":"2024093005204318900_bib79","first-page":"124","article-title":"A study of the PTEN\/MMAC1 gene in 136 breast cancer families","volume":"102","author":"Chen","year":"1998","journal-title":"Hum Genet"},{"key":"2024093005204318900_bib80","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/sj.bjc.6690121","article-title":"Exclusion of a major role for the PTEN tumour-suppressor gene in breast carcinomas","volume":"79","author":"Freihoff","year":"1999","journal-title":"Br J Cancer"},{"key":"2024093005204318900_bib81","first-page":"3657","article-title":"Mutation analysis of the putative tumor suppressor gene PTEN\/MMAC1 in primary breast carcinomas","volume":"57","author":"Rhei","year":"1997","journal-title":"Cancer Res"},{"key":"2024093005204318900_bib82","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00005792-199103000-00003","article-title":"Ataxia-telangiectasia: an interdisciplinary approach to pathogenesis","volume":"70","author":"Gatti","year":"1991","journal-title":"Medicine"},{"key":"2024093005204318900_bib83","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF00216153","article-title":"Absence of linkage to the ataxia telangiectasia locus in familial breast cancer","volume":"92","author":"Wooster","year":"1993","journal-title":"Hum Genet"},{"key":"2024093005204318900_bib84","doi-asserted-by":"crossref","first-page":"S177","DOI":"10.1080\/09553009414552011","article-title":"Cancer risks in A-T heterozygotes","volume":"66","author":"Easton","year":"1994","journal-title":"Int J Radiat Biol"},{"key":"2024093005204318900_bib85","first-page":"1023","article-title":"Loss of heterozygosity and linkage analysis in breast carcinoma: indication for a putative third susceptibility gene on the short arm of chromosome 8","volume":"10","author":"Kerangueven","year":"1995","journal-title":"Oncogene"},{"key":"2024093005204318900_bib86","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/ng1296-430","article-title":"Identification of a RING protein that interacts in vivo with the BRCA1 gene product","volume":"14","author":"Wu","year":"1996","journal-title":"Nat Genet"},{"key":"2024093005204318900_bib87","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1002\/bjs.1800771216","article-title":"Risk of cancer death in first-degree relatives of patients with hereditary non-polyposis cancer syndrome (Lynch type II): a study of 139 kindreds in the United Kingdom","volume":"77","author":"Itoh","year":"1990","journal-title":"Br J Surg"},{"key":"2024093005204318900_bib88","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/ajmg.1320570304","article-title":"Interest in genetic testing among first-degree relatives of breast cancer patients","volume":"57","author":"Lerman","year":"1995","journal-title":"Am J Med Genet"},{"key":"2024093005204318900_bib89","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/(SICI)1097-0142(19970801)80:3+<523::AID-CNCR1>3.0.CO;2-A","article-title":"Survey of cancer genetics: genetic testing implications","volume":"80","author":"Lynch","year":"1997","journal-title":"Cancer"},{"key":"2024093005204318900_bib90","first-page":"381","article-title":"Ethical, social, and counseling issues in hereditary cancer susceptibility","volume":"25","author":"Garber","year":"1995","journal-title":"Cancer Surv"},{"key":"2024093005204318900_bib91","first-page":"1730","article-title":"Genetic testing for cancer susceptibility","volume":"14","author":"American Society of Clinical Oncology","year":"1996","journal-title":"J Clin Oncol"},{"key":"2024093005204318900_bib92","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1349-7006.1999.tb00790.x","article-title":"A case control study on the effectiveness of breast cancer screening by clinical examination in Japan","volume":"90","author":"Kanemura","year":"1999","journal-title":"Jpn J Cancer Res"},{"key":"2024093005204318900_bib93","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S0002-9610(99)00096-3","article-title":"Breast cancer screening","volume":"177","author":"Jatoi","year":"1999","journal-title":"Am J Surg"},{"key":"2024093005204318900_bib94","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s001170050258","article-title":"An integrated early detection concept in women with a genetic predisposition for breast cancer","volume":"37","author":"Bick","year":"1997","journal-title":"Radiologe"},{"key":"2024093005204318900_bib95","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1001\/jama.1993.03500090059033","article-title":"Prospective study of serum CA-125 levels as markers of ovarian cancer","volume":"269","author":"Helzlsouer","year":"1993","journal-title":"JAMA"},{"key":"2024093005204318900_bib96","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1006\/gyno.1993.1239","article-title":"Screening for ovarian cancer: the preliminary experience of a familial ovarian cancer center","volume":"51","author":"Muto","year":"1993","journal-title":"Gynecol Oncol"},{"key":"2024093005204318900_bib97","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/1097-0142(19910801)68:3<458::AID-CNCR2820680303>3.0.CO;2-3","article-title":"Ovarian cancer screening in asymptomatic postmenopausal women by transvaginal sonography","volume":"68","author":"Van Nagell","year":"1991","journal-title":"Cancer"},{"key":"2024093005204318900_bib98","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1001\/jama.1995.03520300065039","article-title":"Ovarian cancer: screening, treatment, and follow-up","volume":"273","author":"National Institutes of Health Consensus Development Panel on Ovarian Cancer","year":"1995","journal-title":"JAMA"},{"key":"2024093005204318900_bib99","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3322\/canjclin.43.1.42","article-title":"Defining and updating the American Cancer Society guidelines for the cancer-related checkup: prostate and endometrial cancers","volume":"43","author":"Mettlin","year":"1993","journal-title":"CA Cancer J Clin"},{"key":"2024093005204318900_bib100","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1200\/JCO.1999.17.2.494","article-title":"Benefits and costs of screening Ashkenazi Jewish women for BRCA1 and","volume":"17","author":"Grann","year":"1999","journal-title":"Brca2. J Clin Oncol"},{"key":"2024093005204318900_bib101","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1056\/NEJM199705153362022","article-title":"Decision analysis\u2014effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations","volume":"336","author":"Schrag","year":"1997","journal-title":"N Engl J Med"},{"key":"2024093005204318900_bib102","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/0002-9610(91)91100-W","article-title":"Technical considerations for prophylactic mastectomy in patients at high risk for breast cancer","volume":"161","author":"Temple","year":"1991","journal-title":"Am J Surg"},{"key":"2024093005204318900_bib103","first-page":"37","article-title":"Bilateral prophylactic mastectomy: issues and concerns","volume":"17","author":"Stefanek","year":"1995","journal-title":"J Natl Cancer Inst Monogr"},{"key":"2024093005204318900_bib104","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/0002-9610(84)90352-0","article-title":"Cancer of the breast after prophylactic subcutaneous mastectomy","volume":"148","author":"Eldar","year":"1984","journal-title":"Am J Surg"},{"key":"2024093005204318900_bib105","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/jso.2930260313","article-title":"Failure of subcutaneous mastectomy to prevent the development of breast cancer","volume":"26","author":"Goodnight","year":"1984","journal-title":"J Surg Oncol"},{"key":"2024093005204318900_bib106","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/00000478-199307000-00009","article-title":"Recurrent secretory carcinoma in residual mammary tissue after mastectomy","volume":"17","author":"Mies","year":"1993","journal-title":"Am J Surg Pathol"},{"key":"2024093005204318900_bib107","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/00006534-197305000-00002","article-title":"Some anatomical considerations of subcutaneous mastectomy","volume":"51","author":"Goldman","year":"1973","journal-title":"Plast Reconstr Surg"},{"key":"2024093005204318900_bib108","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0002-9610(83)90188-5","article-title":"Subcutaneous mastectomy is not a prophylaxis against carcinoma of the breast: Opinion or knowledge?","volume":"145","author":"Humphrey","year":"1983","journal-title":"Am J Surg"},{"key":"2024093005204318900_bib109","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0140-6736(82)92681-2","article-title":"Intra-abdominal carcinomatosis after prophylactic oophorectomy in ovarian cancer-prone families","volume":"ii","author":"Tobacman","year":"1982","journal-title":"Lancet"},{"key":"2024093005204318900_bib110","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1002\/1097-0142(19930501)71:9<2751::AID-CNCR2820710911>3.0.CO;2-J","article-title":"Primary peritoneal carcinoma after prophylactic oophorectomy in women with a family history of ovarian cancer. A report of the Gilda Radner Familial Ovarian Cancer Registry","volume":"71","author":"Piver","year":"1993","journal-title":"Cancer"},{"key":"2024093005204318900_bib111","first-page":"700","article-title":"Should women with familial ovarian cancer undergo prophylactic oophorectomy?","volume":"80","author":"Kerlikowske","year":"1992","journal-title":"Obstet Gynecol"},{"key":"2024093005204318900_bib112","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF00689678","article-title":"The Royal Marsden Hospital pilot tamoxifen chemoprevention trial","volume":"31","author":"Powles","year":"1994","journal-title":"Breast Cancer Res Treat"},{"key":"2024093005204318900_bib113","first-page":"3","article-title":"Raloxifene reduces the risk of breast cancer and may decrease the risk of endometrial cancer in postmenopausal women: two-year findings from the Multiple Outcomes of Raloxifene Evaluation Trial","volume":"17","author":"Cummings","year":"1998","journal-title":"Proceedings of the American Society of Clinical Oncology"},{"key":"2024093005204318900_bib114","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(89)91141-0","article-title":"Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers","volume":"i","author":"Fornander","year":"1989","journal-title":"Lancet"},{"key":"2024093005204318900_bib115","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1177\/107327489700400111","article-title":"Highlights of the NSABP breast cancer prevention trial","volume":"4","author":"Fisher","year":"1997","journal-title":"Cancer Control"},{"key":"2024093005204318900_bib116","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","article-title":"Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 study","volume":"90","author":"Fisher","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"2024093005204318900_bib117","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1136\/bmj.309.6965.1313","article-title":"Tamoxifen and the uterus","volume":"309","author":"Neven","year":"1994","journal-title":"BMJ"},{"key":"2024093005204318900_bib118","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1001\/jama.281.23.2189","article-title":"The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation","volume":"281","author":"Cummings","year":"1999","journal-title":"JAMA"},{"key":"2024093005204318900_bib119","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/BF00052181","article-title":"Exogenous hormone use and the risk of postmenopausal breast cancer: results from The Netherlands Cohort Study","volume":"6","author":"Schuruman","year":"1995","journal-title":"Cancer Causes Control"},{"key":"2024093005204318900_bib120","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0140-6736(96)90806-5","article-title":"Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies","volume":"347","author":"Collaborative Group on Hormonal Factors in Breast Cancer","year":"1996","journal-title":"Lancet"},{"key":"2024093005204318900_bib121","first-page":"419","article-title":"The estimated effect of oral contraceptive use on the cumulative risk of epithelial ovarian cancer","volume":"83","author":"Gross","year":"1994","journal-title":"Obstet Gynecol"},{"key":"2024093005204318900_bib122","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/00001622-199811000-00003","article-title":"Epidemiology, prevention, and early detection of breast cancer","volume":"10","author":"Alberg","year":"1998","journal-title":"Curr Opin Oncol"},{"key":"2024093005204318900_bib123","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/02841869609098472","article-title":"Genetic predisposition to breast cancer","volume":"35","author":"Olsson","year":"1996","journal-title":"Acta Oncol"},{"key":"2024093005204318900_bib124","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1200\/JCO.1999.17.3.1040","article-title":"Attitudes, knowledge, and risk perceptions of women with breast and\/or ovarian cancer considering testing for BRCA1 and","volume":"17","author":"Bluman","year":"1999","journal-title":"Brca2. J Clin Oncol"},{"key":"2024093005204318900_bib125","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1023\/A:1025651816768","article-title":"Knowledge of breast cancer genetics among breast cancer patients and first-degree relatives of affective individuals","volume":"6","author":"Wonderlick","year":"1997","journal-title":"J Genetic Counseling"},{"key":"2024093005204318900_bib126","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0889-8588(05)70014-9","article-title":"Gene therapy for breast cancer","volume":"12","author":"Boxhorn","year":"1998","journal-title":"Hematol Oncol Clin North Am"}],"container-title":["Journal of British Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2168.2000.01347.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2168.2000.01347.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/bjs\/article-pdf\/87\/2\/149\/59438696\/bjs613.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjs\/article-pdf\/87\/2\/149\/59438696\/bjs613.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T05:22:56Z","timestamp":1727673776000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjs\/article\/87\/2\/149\/6156414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,2,1]]},"references-count":126,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2000,2,1]]},"published-print":{"date-parts":[[2000,2,1]]}},"URL":"https:\/\/doi.org\/10.1046\/j.1365-2168.2000.01347.x","relation":{},"ISSN":["0007-1323","1365-2168"],"issn-type":[{"value":"0007-1323","type":"print"},{"value":"1365-2168","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2000,2]]},"published":{"date-parts":[[2000,2,1]]}}}